Beacon Capital Management Inc (Ohio)’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$368 Hold
10
﹤0.01% 109
2025
Q4
$509 Hold
10
﹤0.01% 114
2025
Q3
$555 Hold
10
﹤0.01% 124
2025
Q2
$690 Buy
+10
New +$680 ﹤0.01% 91
2016
Q1
Sell
-8
Closed 296
2015
Q4
$0 Buy
+8
New +$221 ﹤0.01% 334

Other funds holding NVO

Beacon Capital Management Inc (Ohio)'s NVO Position: Q1 2026 in Review

Beacon Capital Management Inc (Ohio) held its Novo Nordisk (NVO) position steady in Q1 2026 at 10 shares worth $368. The position accounts for ﹤0.01% of the portfolio, ranked #109.

Beacon Capital Management Inc (Ohio) first reported a position in NVO in Q4 2015 and has held it in 5 quarters since. The position peaked at $690 in Q2 2025. 1,275 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

  • Beacon Capital Management Inc (Ohio) held 10 shares of Novo Nordisk worth $368 as of Q1 2026.
  • Beacon Capital Management Inc (Ohio) left its Novo Nordisk share count unchanged in Q1 2026.
  • Novo Nordisk made up ﹤0.01% of Beacon Capital Management Inc (Ohio)'s portfolio in Q1 2026, its #109 holding.
  • Beacon Capital Management Inc (Ohio) first reported a position in Novo Nordisk in Q4 2015 and has held it in 5 quarters since.
  • Beacon Capital Management Inc (Ohio)'s Novo Nordisk position peaked at $690 in Q2 2025.
  • 1,275 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on Beacon Capital Management Inc (Ohio)'s 13F filing for Q1 2026, filed 30 Apr 2026.